Phoenix PharmaLabs Exec Describes Novel Non-Addictive Opioid
PPLadmin2020-12-10T20:01:02+00:00Full Article
Research Declares Phoenix PharmaLabs’ Opioid PPL-103 Safe
PPLadmin2020-12-10T19:56:57+00:00Full Article
Phoenix Pharma Labs Technology Transfer Grant
PPLadmin2021-01-19T18:22:11+00:00Phoenix PharmaLabs has received a Technology Transfer Grant from the National Institutes of Health to evaluate its lead compound as a potential treatment for cocaine addiction. Dr. Larry Toll, our CTO, was recruited earlier this year by Florida Atlantic University to become the University's first recruit under the 21st Century World Class Scholars [...]
Pleas to Lawmakers Have Had an Impact
PPLadmin2018-08-14T18:34:12+00:00Perhaps our pleas to lawmakers have had an impact. Please contact your local representatives so they can put some pressure to get this bill approved. The goal of this bill (S. 2260) is to expand, intensify, and coordinate fundamental, translational, and clinical research capabilities of the National Institutes of Health with respect to opioid abuse, [...]